MRI scans to monitor multiple myeloma after stem cell transplant
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study uses MRI scans to check the body for signs of multiple myeloma after a stem cell transplant and before maintenance therapy. It aims to see if MRI can help predict how well the treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have been newly diagnosed with multiple myeloma.
- You must be eligible for a stem cell transplant and have already received a type of induction therapy that includes an anti-CD38 antibody (a targeted treatment).
- You will have had the stem cell transplant, and you must have had an MRI (called DW-MRI) after the transplant but before starting maintenance therapy.
- You must be willing to sign an informed consent form to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced imaging (PET-CT scans) to help doctors better see multiple myeloma in patients who are about to receive CAR T-cell therapy. The goal is to improve how doctors detect and monitor the cancer using a newer type of scan.
This study tests a new imaging agent that may help doctors see multiple myeloma more clearly. It uses a special radioactive tracer that targets a protein found on myeloma cells, which could improve diagnosis and monitoring of the disease.
This study uses a special imaging test called a PET scan to learn more about multiple myeloma and how it responds to treatment. The results may help doctors better predict outcomes and tailor care for people with newly diagnosed disease.
This study tests a new way to make MRI scans look like CT scans to find bone damage from multiple myeloma. You may join if you have just been diagnosed or if your disease came back after strong treatments, and you need bone imaging for staging.
This trial compares two whole-body imaging scans (full-body MRI using DWI and a PET/CT scan) to see which does a better job detecting and staging active multiple myeloma. If you have been newly diagnosed or are being evaluated for suspected symptomatic myeloma, joining could help doctors learn which test is best for planning your care.
This study tests a special CT scan approach (using different X-ray energies) to improve how doctors measure and assess multiple myeloma. It may help ensure imaging results are clearer and more accurate for people with suspected or newly diagnosed myeloma.
Hear when a new Multiple Myeloma (MM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.